412 related articles for article (PubMed ID: 27422817)
1. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
Kobayashi A; Okuda H; Xing F; Pandey PR; Watabe M; Hirota S; Pai SK; Liu W; Fukuda K; Chambers C; Wilber A; Watabe K
J Exp Med; 2011 Dec; 208(13):2641-55. PubMed ID: 22124112
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation of microenvironmental stimuli and role of methylation in bone metastasis from breast carcinoma.
Matteucci E; Maroni P; Disanza A; Bendinelli P; Desiderio MA
Biochim Biophys Acta; 2016 Jan; 1863(1):64-76. PubMed ID: 26481505
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathway for cancer metastasis to bone.
De S; Chen J; Narizhneva NV; Heston W; Brainard J; Sage EH; Byzova TV
J Biol Chem; 2003 Oct; 278(40):39044-50. PubMed ID: 12885781
[TBL] [Abstract][Full Text] [Related]
7. Bone secreted factors induce cellular quiescence in prostate cancer cells.
Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
Shin Y; Kim S; An W
Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
[TBL] [Abstract][Full Text] [Related]
11. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
Jiang X; Liu F; Wang Y; Gao J
J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
[TBL] [Abstract][Full Text] [Related]
12. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.
Buijs JT; Rentsch CA; van der Horst G; van Overveld PG; Wetterwald A; Schwaninger R; Henriquez NV; Ten Dijke P; Borovecki F; Markwalder R; Thalmann GN; Papapoulos SE; Pelger RC; Vukicevic S; Cecchini MG; Löwik CW; van der Pluijm G
Am J Pathol; 2007 Sep; 171(3):1047-57. PubMed ID: 17724140
[TBL] [Abstract][Full Text] [Related]
13. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
14. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
Said N; Frierson HF; Chernauskas D; Conaway M; Motamed K; Theodorescu D
Oncogene; 2009 Oct; 28(39):3487-98. PubMed ID: 19597474
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.
Podgorski I; Linebaugh BE; Koblinski JE; Rudy DL; Herroon MK; Olive MB; Sloane BF
Am J Pathol; 2009 Sep; 175(3):1255-69. PubMed ID: 19700761
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
[TBL] [Abstract][Full Text] [Related]
17. Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold.
Cruz-Neves S; Ribeiro N; Graça I; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Mater Res A; 2017 Jul; 105(7):2035-2046. PubMed ID: 28371333
[TBL] [Abstract][Full Text] [Related]
18. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
Wong SY; Crowley D; Bronson RT; Hynes RO
Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation of SPARC in ovarian cancer.
Socha MJ; Said N; Dai Y; Kwong J; Ramalingam P; Trieu V; Desai N; Mok SC; Motamed K
Neoplasia; 2009 Feb; 11(2):126-35. PubMed ID: 19177197
[TBL] [Abstract][Full Text] [Related]
20. Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer.
López-Moncada F; Torres MJ; Castellón EA; Contreras HR
Asian J Androl; 2019; 21(6):557-564. PubMed ID: 31031331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]